Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Amortization - Intangibles (2023 - 2025)

Historic Amortization - Intangibles for Prime Medicine (PRME) over the last 3 years, with Q3 2025 value amounting to $752000.0.

  • Prime Medicine's Amortization - Intangibles fell 1502.82% to $752000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 5546.57%. This contributed to the annual value of $3.5 million for FY2024, which is 3822.44% down from last year.
  • Per Prime Medicine's latest filing, its Amortization - Intangibles stood at $752000.0 for Q3 2025, which was down 1502.82% from $530000.0 recorded in Q2 2025.
  • Prime Medicine's 5-year Amortization - Intangibles high stood at $2.0 million for Q2 2023, and its period low was $306000.0 during Q4 2024.
  • Its 3-year average for Amortization - Intangibles is $998700.0, with a median of $857500.0 in 2024.
  • As far as peak fluctuations go, Prime Medicine's Amortization - Intangibles plummeted by 7282.42% in 2024, and later plummeted by 1502.82% in 2025.
  • Quarter analysis of 3 years shows Prime Medicine's Amortization - Intangibles stood at $1.1 million in 2023, then plummeted by 72.82% to $306000.0 in 2024, then surged by 145.75% to $752000.0 in 2025.
  • Its last three reported values are $752000.0 in Q3 2025, $530000.0 for Q2 2025, and $339000.0 during Q1 2025.